Cybin Inc (CYBN.NE)

Healthcare | Biotechnology
Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$46.4M

Operating Margin

N/A

Free Cash Flow

-$103M

Debt / Assets

8.3%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Cybin Inc (CYBN.NE).
Income Statement (Quarterly) 2025-09-30 2025-06-30 2024-12-31 2024-09-30
Revenue 0 0 0 0
Cost of Revenue 39,942 52,588 0 0
Gross Profit -39,942 -52,588 0 0
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 13,793,834 9,629,000 11,582,000 48,816,000
Operating Expenses 39,756,267 24,624,000 31,304,000 58,254,000
Operating Income -28,894,000 -24,624,000 -31,304,000 -58,254,000
Interest Expense 0 4,036,847 0 0
Income Before Tax -33,722,000 -24,613,000 -10,542,000 -57,192,000
Income Tax Expense 0 0 0 0
Net Income -46,445,898 -24,613,000 -10,542,000 -57,192,000
Per Share
EPS -1.92 -1.10 -0.53 -2.86
EPS Diluted 0.00 0.00 0.00 0.00